Bachem hosts repeat of its ‘Beyond Automation’ webinar on smart factory vision

Bubendorf, Switzerland: – Leading CDMO Bachem is hosting a repeat of its online webinar illustrating its transformation journey to Industry 4.0 model smart factories for its peptides and oligonucleotides manufacturing operations.

The Webinar ‘Beyond automation: Towards a smart factory’ will again be hosted as a free-to-register event on Tuesday, November 22,  2022, commencing 0830 hrs. CET (UTC +1) and lasting approximately one hour. Registration for the event can be completed online (see Resources).

Advanced process automation

Bachem is constantly striving to improve its industry standards by developing innovative and efficient large-scale manufacturing processes for active pharmaceutical ingredients (APIs).

The webinar will explain how Bachem operations have entered the Industry 4.0 era and started their business transformation towards a smart factory.

Focusing on solid-phase peptide synthesis (SPPS) process as a case study, the session show how Bachem has used process automation to optimize equipment usage, reduce operating times, and increase the flexibility of production.

Digitalization strategy

Lead presenter will again be Bachem MSAT Group Leader Dr. Patrizia Marchetti, who will this time be joined by Aya Ito, Business Development Manager at Bachem Japan. Together they will also report on the benefits of Bachem’s digitalization strategy, including paperless documentation, improved first-time right rates, data analytics, and higher data safety and integrity.

Dr. Marchetti leads the Manufacturing Science and Technology (MSAT ) process engineering group at Bachem Bubendorf. Her team focuses on the design and implementation of new processes and equipment for the manufacturing of API. Before joining Bachem in 2017, Patrizia worked as a researcher at Lonza AG in Visp and at Imperial College London, developing nanofiltration-assisted processes for peptides and oligonucleotides.

Aya Ito is Bachem Japan’s Business Development Manager with responsibilities for both NCE and Generic API businesses mainly in Eastern Asia including China, South Korea, and Taiwan. She has more than ten years experience in the pharma industry, having gained her B.Sc. in Biology and Chemistry from Midwestern University, TX, USA and MSc. in Cell and Molecular Biology from Texas Tech University Health Science Center.

About Bachem

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

For further information, see www.bachem.com.

Resources

Click on Bachem webinar ‘Beyond Automation: Towards a Smart Factory’ to register for the event.
Click on Bachems News to see latest News & Events.